BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2248848)

  • 1. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
    Lehmann-Horn F; Iaizzo PA
    Br J Anaesth; 1990 Nov; 65(5):692-7. PubMed ID: 2248848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases.
    Adnet PJ; Krivosic-Horber RM; Krivosic I; Haudecoeur G; Reyford HG; Adamantidis MM; Medahoui H
    Br J Anaesth; 1994 Jan; 72(1):93-7. PubMed ID: 8110560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle.
    Williams JH; Lee JC; Holland M
    Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):253-6. PubMed ID: 1439194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
    Ilias WK; Williams CH; Fulfer RT; Dozier SE
    Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs.
    Iaizzo PA; Klein W; Lehmann-Horn F
    Pflugers Arch; 1988 Jun; 411(6):648-53. PubMed ID: 3412868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia: normal muscle calcium uptake and abnormal caffeine and halothane contractures.
    Jaffe RS; Martucci RW; Gronert GA; Elliott TE; Cardinet GH
    Anesthesiology; 1991 Sep; 75(3):525-6. PubMed ID: 1888058
    [No Abstract]   [Full Text] [Related]  

  • 9. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro determination of susceptibility to malignant hyperthermia.
    Iaizzo PA; Lehmann-Horn F
    Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
    Olgin J; Rosenberg H; Allen G; Seestedt R; Chance B
    Anesth Analg; 1991 Jan; 72(1):36-47. PubMed ID: 1984374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests.
    Ording H; Skovgaard LT
    Acta Anaesthesiol Scand; 1987 Jul; 31(5):458-61. PubMed ID: 3630590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
    Ording H
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA; Wedel DJ; Gallagher WJ
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of midazolam on directly stimulated muscle biopsies from control and malignant hyperthermia positive patients.
    Fletcher JE; Rosenberg H; Hilf M
    Can Anaesth Soc J; 1984 Jul; 31(4):377-81. PubMed ID: 6146391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
    McKenzie AJ; Couchman KG; Pollock N
    Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tests of contracture and sensitivity to malignant hyperthermia in 27 patients].
    Krivosic-Horber R; Adnet P; Krivosic I; Theunynck D; Guévart E; Adamantidis M
    Ann Fr Anesth Reanim; 1988; 7(2):132-8. PubMed ID: 3364812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro contracture tests for susceptibility to malignant hyperthermia.
    Rosenberg H; Reed S
    Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945
    [No Abstract]   [Full Text] [Related]  

  • 19. BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers.
    Williams JH; Holland M; Lee JC; Ward CW; McGrath CJ
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R782-6. PubMed ID: 1718170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
    Fletcher JE; Rosenberg H
    Anesthesiology; 1985 Aug; 63(2):190-4. PubMed ID: 4025868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.